Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19296597rdf:typepubmed:Citationlld:pubmed
pubmed-article:19296597lifeskim:mentionsumls-concept:C1423062lld:lifeskim
pubmed-article:19296597lifeskim:mentionsumls-concept:C1420071lld:lifeskim
pubmed-article:19296597lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:19296597lifeskim:mentionsumls-concept:C0439098lld:lifeskim
pubmed-article:19296597pubmed:issue7lld:pubmed
pubmed-article:19296597pubmed:dateCreated2009-4-2lld:pubmed
pubmed-article:19296597pubmed:abstractTextN()-Thioacetyl-lysine-containing tri-, tetra-, and pentapeptides, based on the alpha-tubulin and p53 protein sequences, were studied as SIRT1 and SIRT2 inhibitors. The potency of the pentapeptides depended on the selection of the side chains. The removal of N- and C-terminal residues of the pentapeptides yielded tripeptides with retained SIRT1 inhibitory activity but decreased SIRT2 inhibitory activity. The most potent SIRT1 inhibitors were equipotent with the reference compound (6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide) with the IC(50) values of 180-330 nM.lld:pubmed
pubmed-article:19296597pubmed:languageenglld:pubmed
pubmed-article:19296597pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:citationSubsetIMlld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19296597pubmed:statusMEDLINElld:pubmed
pubmed-article:19296597pubmed:monthAprlld:pubmed
pubmed-article:19296597pubmed:issn1520-4804lld:pubmed
pubmed-article:19296597pubmed:authorpubmed-author:SalminenAnter...lld:pubmed
pubmed-article:19296597pubmed:authorpubmed-author:LeppänenJukka...lld:pubmed
pubmed-article:19296597pubmed:authorpubmed-author:WallénErik...lld:pubmed
pubmed-article:19296597pubmed:authorpubmed-author:PosoAnttiAlld:pubmed
pubmed-article:19296597pubmed:authorpubmed-author:SuuronenTiina...lld:pubmed
pubmed-article:19296597pubmed:authorpubmed-author:JarhoElina...lld:pubmed
pubmed-article:19296597pubmed:authorpubmed-author:KyrylenkoSerg...lld:pubmed
pubmed-article:19296597pubmed:authorpubmed-author:TervonenJussi...lld:pubmed
pubmed-article:19296597pubmed:authorpubmed-author:KivirantaPäiv...lld:pubmed
pubmed-article:19296597pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19296597pubmed:day9lld:pubmed
pubmed-article:19296597pubmed:volume52lld:pubmed
pubmed-article:19296597pubmed:ownerNLMlld:pubmed
pubmed-article:19296597pubmed:authorsCompleteYlld:pubmed
pubmed-article:19296597pubmed:pagination2153-6lld:pubmed
pubmed-article:19296597pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:19296597pubmed:meshHeadingpubmed-meshheading:19296597...lld:pubmed
pubmed-article:19296597pubmed:meshHeadingpubmed-meshheading:19296597...lld:pubmed
pubmed-article:19296597pubmed:meshHeadingpubmed-meshheading:19296597...lld:pubmed
pubmed-article:19296597pubmed:meshHeadingpubmed-meshheading:19296597...lld:pubmed
pubmed-article:19296597pubmed:meshHeadingpubmed-meshheading:19296597...lld:pubmed
pubmed-article:19296597pubmed:meshHeadingpubmed-meshheading:19296597...lld:pubmed
pubmed-article:19296597pubmed:meshHeadingpubmed-meshheading:19296597...lld:pubmed
pubmed-article:19296597pubmed:meshHeadingpubmed-meshheading:19296597...lld:pubmed
pubmed-article:19296597pubmed:meshHeadingpubmed-meshheading:19296597...lld:pubmed
pubmed-article:19296597pubmed:year2009lld:pubmed
pubmed-article:19296597pubmed:articleTitleN(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.lld:pubmed
pubmed-article:19296597pubmed:affiliationDepartment of Pharmaceutical Chemistry, Institute of Clinical Medicine, University of Kuopio, Kuopio, Finland.lld:pubmed
pubmed-article:19296597pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19296597pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:19296597lld:chembl